E11. New targets and new agents on the horizon for lung cancer therapy

Lung Cancer ◽  
2005 ◽  
Vol 49 ◽  
pp. S18-S19
Author(s):  
Paul A. Bunn
Keyword(s):  
Lung Cancer ◽  
Cancer Therapy ◽  
New Agents ◽  
New Targets ◽  
Lung Cancer Therapy

New targets for non-small-cell lung cancer therapy

2007 ◽  
Vol 7 (10) ◽  
pp. 1423-1437 ◽  
Author(s):  
Manrique Alvarez ◽  
Eloy Roman ◽  
Edgardo S Santos ◽  
Luis E Raez
Keyword(s):  
Lung Cancer ◽  
Cancer Therapy ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
New Targets ◽  
Lung Cancer Therapy

Enhancement of gold-nanocluster-mediated chemotherapeutic efficiency of cisplatin in lung cancer

2021 ◽  
Author(s):  
Mei Jiang ◽  
Yuchen Lin ◽  
Xiaocui Fang ◽  
Mingpeng Liu ◽  
Lilusi Ma ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Therapy ◽  
Delivery System ◽  
Gold Nanoclusters ◽  
Cationic Peptide ◽  
Gold Nanocluster ◽  
Lung Cancer Therapy ◽  
Anti Tumor Activity

A novel delivery system for cisplatin based on electrostatics-mediated assemblies of gold nanoclusters and PEGylated cationic peptide was constructed. The constructed cisplatin@GC-pKs showed much enhanced anti-tumor activity for lung cancer therapy.

Nanomedicine as an emerging platform for metastatic lung cancer therapy

2015 ◽  
Vol 34 (2) ◽  
pp. 291-301 ◽  
Author(s):  
Dalit Landesman-Milo ◽  
Srinivas Ramishetti ◽  
Dan Peer
Keyword(s):  
Lung Cancer ◽  
Cancer Therapy ◽  
Metastatic Lung Cancer ◽  
Metastatic Lung ◽  
Lung Cancer Therapy

scholarly journals Nutlin-3 inhibits the NFκB Pathway in a p53 Dependent Manner: Implications in Lung Cancer Therapy

Cell Cycle ◽  
2007 ◽  
Vol 6 (17) ◽  
pp. 2178-2185 ◽  
Author(s):  
Anwesha Dey ◽  
E.T. Wong ◽  
P. Bist ◽  
V. Tergaonkar ◽  
David Lane
Keyword(s):  
Lung Cancer ◽  
Cancer Therapy ◽  
Dependent Manner ◽  
Lung Cancer Therapy ◽  
Nfκb Pathway
Sign in / Sign up

Export Citation Format

Share Document